Tower Research Capital LLC (Trc) Exagen Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Exagen Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,327 shares of XGN stock, worth $5,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,327
Previous 1,312
1.14%
Holding current value
$5,122
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Rtw Investments, LP New York, NY1.51MShares$5.84 Million0.1% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$3.44 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$2.07 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$1.87 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $62.8M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...